Johnson & Johnson CPU is currently recruiting healthy male and female volunteers between the age of 18 and 60 years (inclusive) to participate in a study with study medication for the treatment of psoriasis. Do you meet the main admission requirement below? Then you may be eligible to participate in the study.
Main admission requirements
- You are between 18 and 30 years of age (inclusive)
- You have a BMI between 18.0 to 30.0 km/m² (inclusive)
- You have a weight of at least 50kg
- No use of nicotine-containing substances (e.g., cigar, nicotine patch, or e-cigarette) for 6 months before the screening and no smoking until the end of the study.
- You feel generally healthy and have no history of any particular illnesses
- You do not participate in other studies from 30 days before screening OR 5 x the half-life of the study medication taken from a previous study. (note: longest period applies)
- As a woman, you are:
- Either postmenopausal - If you did not have a period for more than 12 months.
- Either sterilized - After the removal of ovaries and/or uterus, the fallopian tubes are clamped or blocked.
- Either: effective contraceptive method
- You are not an employee or family member of personnel employed by Johnson & Johnson.
- You have reviewed the complete recruitment letter with detailed terms and conditions, explanation of selection process and fees (see pdf documents attached).
- You can completely free up your schedule to participate in 1 or more groups.
Study compensation
If you participate in this study, you will receive compensation for the time and commitment invested. You will receive a mileage reimbursement for each visit.
- € 55 voor de screening
- € 4310 (including screening compensation) for the full study
- € 295 (including screening compensation) for the reserve
- € 150 (including screening compensation) for the standby
Study process
The study consists of 2 parts: Part 1 of the study consists of 8 (optional) groups with 8 participants per group. Part 2 of the study consists of 2 groups with 6 participants per group. You can only participate in one part of the study. The study is conducted after formal approval by the Ethics Committee and includes the following:
- Initial screening visit
- You will read the informed consent form (ICF). Following this, there will be a discussion with a physician, and you will have the opportunity to ask questions. If you wish to participate in the study, both you and the physician will sign the form. The physician will review your medical history and medication use with you. Depending on the study, other additional examinations may also take place, such as a physical examination, measuring weight, blood pressure, temperature, heart monitoring, blood and urine tests, a pregnancy test, alcohol and/or drug tests, or other tests.
- Possible follow-up visits
- During the entire study, additional examinations may be scheduled, such as additional blood tests or a visit for a specialized examination.
- 4 Stays
- 4 days and 3 nights each
- Leaving the unit and receiving visitors during the stay is not allowed
- 1 Follow-up visit
- You will undergo a final examination to check your health status one last time. This marks the end of your participation in the study.
How to register?
Be sure to review the complete recruitment letter with detailed conditions, explanation of selection process and fees (see pdf's on this page). Check if you can free yourself in your schedule to join 1 or more groups.
Preferably register online, namely through:
- Website
- Press the “Register for this study” button on this webpage.
- Phone
- During office hours (08:00 AM - 05:00 PM), you can also register by phone at 0800 97 886 or +32(0)3 640 32 30.
Your response to this recruitment letter only indicates your interest in obtaining information and does not guarantee participation in the study.